abstract |
The invention relates to the use of novel and known lipase-inhibitorily active compounds of general formula (I), wherein Al, A2, R2 and Z have the meanings as defined in the description, for the treatment and/or prophylaxis of obesity as well as accompanying diseases and/or secondary diseases associated with obesity. |